These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23028722)

  • 1. A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
    Amorim JH; Pereira Bizerra RS; dos Santos Alves RP; Sbrogio-Almeida ME; Levi JE; Capurro ML; de Souza Ferreira LC
    PLoS One; 2012; 7(9):e44984. PubMed ID: 23028722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome.
    Tuiskunen A; Wahlström M; Bergström J; Buchy P; Leparc-Goffart I; Lundkvist A
    Virol J; 2011 Aug; 8():398. PubMed ID: 21835036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.
    Alves RPDS; Pereira LR; Fabris DLN; Salvador FS; Santos RA; Zanotto PMA; Romano CM; Amorim JH; Ferreira LCS
    Clin Vaccine Immunol; 2016 Jun; 23(6):460-469. PubMed ID: 27030586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune response.
    Marcos E; Lazo L; Gil L; Izquierdo A; Suzarte E; Valdés I; Blanco A; Ancizar J; Alba JS; Pérez Yde L; Cobas K; Romero Y; Guillén G; Guzmán MG; Hermida L
    Immunol Lett; 2016 Aug; 176():51-6. PubMed ID: 27233365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model.
    Amorim JH; dos Santos Alves RP; Bizerra R; Araújo Pereira S; Ramos Pereira L; Nascimento Fabris DL; Santos RA; Romano CM; de Souza Ferreira LC
    Virology; 2016 Jan; 487():41-9. PubMed ID: 26496698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor.
    Perry ST; Buck MD; Lada SM; Schindler C; Shresta S
    PLoS Pathog; 2011 Feb; 7(2):e1001297. PubMed ID: 21379341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models of dengue virus infection and disease.
    Yauch LE; Shresta S
    Antiviral Res; 2008 Nov; 80(2):87-93. PubMed ID: 18619493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection.
    Wan SW; Chen PW; Chen CY; Lai YC; Chu YT; Hung CY; Lee H; Wu HF; Chuang YC; Lin J; Chang CP; Wang S; Liu CC; Ho TS; Lin CF; Lee CK; Wu-Hsieh BA; Anderson R; Yeh TM; Lin YS
    J Immunol; 2017 Oct; 199(8):2834-2844. PubMed ID: 28904127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue virus 3 clinical isolates show different patterns of virulence in experimental mice infection.
    Ferreira GP; Figueiredo LB; Coelho LF; S PA; Cecilio AB; Ferreira PC; Bonjardim CA; Arantes RM; Campos MA; Kroon EG
    Microbes Infect; 2010 Jul; 12(7):546-54. PubMed ID: 20381635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice.
    White LJ; Parsons MM; Whitmore AC; Williams BM; de Silva A; Johnston RE
    J Virol; 2007 Oct; 81(19):10329-39. PubMed ID: 17652394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice.
    Pan P; Zhang Q; Liu W; Wang W; Lao Z; Zhang W; Shen M; Wan P; Xiao F; Liu F; Zhang W; Tan Q; Liu X; Wu K; Liu Y; Li G; Wu J
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and genotypic characterization of dengue virus isolates differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome.
    Tuiskunen A; Monteil V; Plumet S; Boubis L; Wahlström M; Duong V; Buchy P; Lundkvist A; Tolou H; Leparc-Goffart I
    Arch Virol; 2011 Nov; 156(11):2023-32. PubMed ID: 21922323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach.
    Shan C; Xie X; Zou J; Züst R; Zhang B; Ambrose R; Mackenzie J; Fink K; Shi PY
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.
    Sarathy VV; White M; Li L; Gorder SR; Pyles RB; Campbell GA; Milligan GN; Bourne N; Barrett AD
    J Virol; 2015 Jan; 89(2):1254-66. PubMed ID: 25392217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model.
    Barros VE; dos Santos-Junior NN; Amarilla AA; Soares AM; Lourencini R; Trabuco AC; Aquino VH
    BMC Microbiol; 2015 Sep; 15():189. PubMed ID: 26415508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of Aedes albopictus Mosquito C6/36 Cells with the
    Teramoto T; Huang X; Armbruster PA; Padmanabhan R
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variation of dengue type 2 virus isolated from clinical cases in Thailand.
    Kurosu T; Chaichana P; Phanthanawiboon S; Khamlert C; Yamashita A; A-nuegoonpipat A; Ikuta K; Anantapreecha S
    Jpn J Infect Dis; 2014; 67(2):132-4. PubMed ID: 24647259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NS1 glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease.
    Falconar AK; Martinez F
    PLoS One; 2011; 6(6):e21024. PubMed ID: 21731643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.